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ABSTRACT: 
 
The cuprizone mouse model is well-established for studying the processes of both 
demyelination and remyelination in the corpus callosum, and it has been utilized together 
with diffusion tensor imaging (DTI) to investigate myelin and axonal pathology. Although 
some underlying morphological mechanisms contributing to the changes in diffusion 
tensor (DT) metrics have been identified, the understanding of specific associations 
between histology and diffusion measures remains limited. Diffusional kurtosis imaging 
(DKI) is an extension of DTI that provides metrics of diffusional non-Gaussianity, for which 
an associated white matter modeling (WMM) method has been developed.  The main goal 
of the present study was to quantitatively assess the relationships between diffusion 
measures and histological measures in the mouse model of cuprizone-induced corpus 
callosum demyelination. The diffusional kurtosis (DK) and WMM metrics were found to 
provide additional information that enhances the sensitivity to detect the morphological 
heterogeneity in the chronic phase of the disease process in the rostral segment of the 
corpus callosum. Specifically, in the rostral segment axonal water fraction (d = 2.6;      
p<0.0001), radial kurtosis (d = 2.0; p=0.001) and mean kurtosis (d = 1.5; p=0.005) showed 
the most sensitivity between groups with respect to yielding statistically significant p-
values and high Cohen's d values. These results demonstrate the ability of DK and WMM 
metrics to detect white mater changes and inflammatory processes associated with 
cuprizone-induced demyelination.  They also validate, in part, the application of these new 
WMM metrics for studying neurological diseases, as well as help to elucidate their 
biophysical meaning. 
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INTRODUCTION 
The cuprizone mouse model (1-3) is well-established for studying the processes of 
both demyelination and remyelination in the corpus callosum. In this model, young adult 
mice are fed the copper chelator cuprizone (bis-cyclohexanone oxaldihydrazone), leading 
to reproducible central nervous system (CNS) demyelination within weeks. Removal of the 
toxin from their diet results in spontaneous remyelination (4,5). Cuprizone intoxication 
follows a consistent pattern with loss of myelin and oligodendrocytes during the first 3 to 4 
weeks of cuprizone administration accompanied by recruitment of microglia, macrophages 
and astrocytes (acute demyelination); as a response to the demyelination process, 
oligodendrocyte progenitors begin to accumulate within the lesion and after 5 or 6 weeks 
of continuous cuprizone administration, demyelination is intense (subacute demyelination) 
and spontaneous remyelination starts to occur. With continued cuprizone administration 
and successive waves of demyelination, a chronically demyelinated state is reached. 
Considerable variation in the degree of myelination of the different segments of the corpus 
callosum is apparent at all stages of the process (5-8). This mouse model develops both 
motor and behavioral deficiencies, that correlate well with the extent of demyelination 
(9,10). 
Both in-vivo and ex-vivo diffusion tensor imaging (DTI) have been used to quantify 
myelin and axonal pathology in the CC of the cuprizone mouse model (11-20). Broadly, 
these reports have shown a decrease in axial diffusivity (D||) and an increase in radial 
diffusivity (D┴) associated with the process of demyelination. Significant correlations 
between such diffusion tensor (DT) metrics and histological measurements of tissue 
damage have also been reported (14,18,20). Although some underlying morphological 
mechanisms contributing to the changes in DT metrics have been proposed (14,16,18), 
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the understanding of specific associations between histology and diffusion measures is 
still limited. 
Diffusional kurtosis imaging (DKI) is an extension of DTI that provides, in addition 
to the conventional DT metrics, diffusional non-Gaussianity metrics as quantified by the 
kurtosis of the diffusion displacement probability density function (21-23). These extra 
diffusional kurtosis (DK) metrics, including mean kurtosis (MK), axial (K//) and radial 
kurtoses (K┴), are unavailable with DTI, which is based on a Gaussian diffusion signal 
model. The DK metrics are complementary to the DT metrics and serve to more 
completely characterize tissue microstructure. 
Recently, DKI has been applied in humans to study several brain diseases (24-34) 
resulting in novel observations. Additionally, animal studies have shown that DK metrics 
can help differentiate brain tissues (35) and are sensitive to changes in brain 
microstructure associated with aging (36), Aβ deposition (37,38), stroke (39-40), axonal 
degeneration in the autoimmune encephalomyelitis rat model (41), traumatic brain injury 
(42) and developmental changes in a rat model of Huntington’s disease (43).  
 In order to better understand the biophysical meaning of diffusion metrics in the 
brain, tissue modeling has frequently been employed to construct explicit links to various 
microstructural properties, such as cell densities and sizes, as well as to compartment-
specific diffusion properties. One approach, referred to as white matter modeling (WMM), 
has been developed specifically for the analysis of DKI data in white matter (44). Briefly, 
this method relates DKI data to several microstructural parameters: the axonal water 
fraction (AWF); the intrinsic diffusivity inside the axons, Da; the axial and radial diffusivities 
in the extra-axonal space (EAS), De,|| and De,┴ respectively; and tortuosity (α) of the EAS 
defined as De,||/De,┴. Although the relationship between these indices and pathological 
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tissue changes can be subtle, AWF is expected to be particularly sensitive to axonal loss, 
while De,┴ and α are expected to be particularly sensitive to demyelination, but can also be 
related to other changes in extra-axonal diffusion, e.g., extracellular inflammation. In a 
recent application of this WMM model, our group was able to distinguish normal subjects 
from subjects with mild cognitive impairment (MCI), particularly in the corpus callosum 
(45), and to show that myelin in late-myelinating white matter tracts preferentially 
deteriorates in the course of Alzheimer’s disease (46).  
The goal of this study is to quantitative characterize the DK-WMM metrics in the 
chronic stage of demyelination in the cuprizone mouse model, and to investigate the 
correspondence between changes in diffusion metrics and morphological alterations 
associated with myelin pathology. These results may be of value for interpreting DKI-
based studies of neurological disorders, such as multiple sclerosis and Alzheimer’s 
disease, for which myelin changes are believed to play a prominent role. 
MATERIALS AND METHODS 
Animal Model 
 A total of 20 (8-10 week old) male C57BL/6 mice (Charles River Laboratories, 
Wilmington, MA) were used in this study. The cuprizone treated group (CPZ; n=10) were 
fed a diet containing cuprizone (0.2%), (Bis(cyclohexanone) oxaldihydrazone, Sigma-
Aldrich) mixed into milled chow pellets for a period of 10 weeks to induce a chronic state 
of CNS demyelination. The control group (NC; n=10) was maintained on a normal diet for 
10 weeks. All experimental procedures were approved by the Institutional Animal Care 
and Use Committee at Nathan Kline Institute and Medical University of South Carolina, 
and in accordance with the National Institutes of Health (NIH) Guide for Care and Use of 
Laboratory Animals. All animals were housed in temperature- and humidity-controlled 
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rooms on a 12-h light/dark cycle (lights on at 6:00 AM) in an accredited animal care 
facility. 
MRI Protocol 
 Mice were anesthetized using an isoflurane vaporizer set at the following 
percentages: 3% for induction, 2% during pilot scanning, and 1.5% during data 
acquisition. An animal monitoring unit (SA instruments, Inc., model 1025, Stony Brook, 
NY) was used to record respiration and rectal temperature. Respiration was measured 
with a pressure transducer placed under the abdomen just below the ribcage. Body 
temperature was maintained using forced warm air, controlled by a feedback circuit 
between the heater and thermistor. After induction, mice were placed on a holder and 
restrained using a bite bar and ear bars placed half way into the auditory canal. Oxygen 
was used as the carrier gas and delivered at a low flow rate (≤ 0.5 L/min.) to a cone 
positioned before the bite bar, where gases mixed with air and passed over the rodent’s 
nose.  All animals were maintained at 37.0 ± 0.2 °C and respiration ranged between 50 to 
70 breaths per minute with a median heart rate of 500 beats per minute during scanning. 
All data were obtained on a 7.0 T Agilent (Santa Clara, CA) 40 cm bore system. The 
gradient coil insert had an internal diameter of 12 cm with a maximum gradient strength of 
600 mT/m and minimum rise time of 200 µs with customized second and third order shim 
coils.  A Rapid (Rimpar, Germany) volume transmit coil (72 mm ID) and a 2 channel 
receive-only surface coil was used for RF transmission and reception, respectively. A 
respiration-gated 4-shot SE-EPI sequence was used for DKI acquisition. The sequence 
parameters were: TR/TE=3000/30ms, δ/Δ=5/17ms, slices=7, slice thickness = 1mm, data 
matrix = 128 × 128, image resolution = 234 × 234 μm2, number of averages = 4, 30 
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gradient directions (47) and 5 b-values for each gradient direction (0.5, 1.0, 1.5, 2.0 and 
2.5 ms/μm2). 
 DKI post-processing was performed using in-house software (48) 
(http://nitrc.org/projects/dke). The software generates parametric maps by fitting the DKI 
signal model (21,22) to the diffusion MRI (dMRI) signal measurements for each voxel 
using a linearly constrained weighted linear least squares fitting algorithm (Tabesh et al., 
2011), resulting in parametric maps of the conventional DT metrics of mean diffusivity 
(MD), D||, D┴, and fractional anisotropy (FA), as well as the additional kurtosis metrics of 
MK, K||, and K┴. All of these metrics are estimated from the DT and DK tensors (22). The 
MD corresponds to the diffusivity averaged over all possible diffusion directions, D|| 
corresponds to the diffusivity in the direction of the principal diffusion tensor eigenvector, 
and D┴ corresponds to the diffusivity averaged over all diffusion directions perpendicular 
to the principal diffusion tensor eigenvector. The additional metrics of MK, K|| and K┴, are 
kurtosis analogs of MD, D|| and D┴ that quantify the diffusional non-Gaussianity (21). It is 
worth noting that, due to the inclusion of non-Gaussian effects, the DKI-derived estimates 
of diffusivities will generally be more accurate than those obtained with DTI (49). In 
addition, parametric maps were estimated for WMM metrics of: AWF, Da, De,||, De,┴ and α 
as described previously (44). 
 Brain regions of interest (ROIs) at the level of corpus callosum (rostral (aCC), 
middle (bCC), and caudal (pCC)) were manually drawn on the FA map using ImageJ 
software (version 1.42q; http://rsb.info.nih.gov/ij/) (50) (Fig.1). To meet the WMM 
assumption (44) of fiber bundles that are highly oriented in a uniform parallel pattern, we 
limited the ROIs to the center of the CC at each level. We sampled two MRI slices for aCC 
and bCC and one MRI slice at the level of pCC. All ROIs contained at least 9 voxels. The 
7 
 
average regional value for each metric was obtained from the voxels within each ROI. To 
minimize the effect of cerebrospinal fluid (CSF) contamination, all voxels with MD>1.5 
μm2/ms were excluded from the ROIs prior to parameter quantification.  
Histological Protocol 
 Following the MRI scan, while still under anesthesia, mice were perfused with ice-
cold phosphate buffered saline (PBS) followed by paraformaldehyde (4%) in PBS. Mice 
brains were then removed and post-fixed overnight in the same fixative, and then 
transferred to a storage buffer (Na Cacodylate). All mice brain samples were processed 
by NeuroScience Associates (Knoxville, TN) using MultiBrain® Technology, where 25 
mouse brains are embedded together per block, and freeze-sectioned at 30 μm in the 
coronal plane through the CC area of the mouse brain (~3 mm in length). Sections were 
stained free-floating at room temperature for: A) Solochrome to reveal myelin (51); B) 
Amino cupric silver to reveal axonal degeneration (52); C) Glial fibrillary acidic protein 
(GFAP)  to reveal astrocyte activity (53), and D) ionized calcium binding adapter molecule 
1 (Iba1) to reveal microglia (54).  It is important to note that all immunohistochemistry 
(IHC), for each antibody, was performed at the same time for all sections used in the 
quantitative analysis. 
 All slices were then digitized using a National Optical model DC5-163 SD Series 
digital microscope with a built-in 2.0 mega pixel camera and version 2.0 of Motic® Images 
Plus software. All slices for each histological marker were imaged in one session to avoid 
possible image intensity variation. Images (4x magnification) were acquired and split into 
multicolor channels. The blue channel was chosen for the solochrome stain images and 
the red channel for the amino cupric silver and GFAP and Iba1 IHC images. The channels 
were then converted and saved as 8-bit grayscale (1600 x 1200 pixels) images. 
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Approximately 18 consecutive 30 μm corpus callosum histological digital images were 
analyzed for each mouse using ImageJ. The immuno-stain intensity for each of the 
digitized images was then quantified. Histological ROIs at the level of corpus callosum 
were manually drawn, centered at bregma 1.10 for rostral (aCC), -1.46 for middle (bCC) 
and -2.54 for caudal (pCC) segments (Figure 1) (55). For each immuno-stain, the mean 
intensity values from all pixels in each ROI were averaged.  In this analysis, we used the 
mean intensity value to represent the degree of histological staining. 
Statistical Analysis: 
 One-way ANOVA, corrected for multiple comparisons using the Sidak method, 
was performed to compare the means of the two groups for all the metrics. All error bars 
correspond to the standard error of the mean (SEM).  
Spearman’s rank correlation was used to examine the association between 
diffusion metrics and immunohistochemistry metrics.  The correlation analysis was 
performed for the entire CC, including all three segments for each group (control and 
cuprizone) separately (intra-group correlations), based on z-scores from values obtained 
at each CC segment.  The z-score for each mouse and each metric was calculated as the 
departure from the mean of the control group for each segment of the CC, divided by the 
standard deviation of the control group (z-score = (metric – NC mean)/NC stdev). 
To investigate which morphological, diffusion and WMM metrics would yield the 
strongest differentiation between the NC and CPZ an effect size (Cohen's d) was 
calculated for each metric at each CC level. All analyses were performed using SPSS 
version 20.0 (IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp).  
All reported p values were considered statistically significant at p ≤ 0.05. 
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RESULTS:  
Morphological and Diffusion MRI Assessment for the Control Group 
Here we present an overview of the control group, based on a two-tailed t-test for 
two samples of equal variance, uncorrected; the mean values for all morphological and 
diffusion metrics are presented in Tables 1-4.  
In agreement with the morphological heterogeneity previously described between 
the segments of the CC [56-61], our histological results for the control group 
demonstrated a lesser degree of myelination in the aCC compared with bCC and pCC. 
Interestingly, our results also showed more microglia cells in the aCC and bCC when 
compared with pCC, but no differences in the number of astrocytes. Finally, the amino 
cupric silver stain revealed some degree of axonal damage in the aCC, when compared 
with bCC and pCC. 
The diffusion MRI results for the control group associated well with the 
morphological aspects in each CC segment. Briefly, FA had a caudal-rostral pattern, 
where higher FA was present in the pCC, accompanied by higher D||, De,|| and α values, 
and with lower D┴ and De,┴ values compared with aCC and bCC. This is probably due to 
the high density/packing of highly myelinated axons at this level.  FA was also higher in 
the bCC when compared with aCC, with lower D┴, K┴, De,┴, perhaps due to the presence 
of highly myelinated axons and a broader distribution in axonal caliber and more extra-
cellular space than aCC.  No MD, MK, AWF or Da differences were detected between the 
three CC segments in the control group.   
Morphological and Diffusion MRI Assessment between Groups 
Histological Assessment  
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As expected, after 10 weeks of cuprizone treatment, which is considered a chronic 
phase, the Solochrome stain revealed intense, complete demyelination in the CC of the 
CPZ mice, as indicated by higher pixel intensity values relative to NC mice. The aCC was 
characterized by being the least affected segment and the one with the greatest 
morphological heterogeneity. Group differences were statistically significant in all three 
regions of the CC. The demyelination process was accompanied by mild 
neurodegeneration and intense inflammation represented by the statistically significant 
increase in the amino cupric silver stain and in the immunoreactivity for Iba1 
(macrophage/microglia) and GFAP (astrocyte activity) markers in the CPZ group.  For the 
entire CC, and in each of the three regions of the CC, the inflammatory markers GFAP 
and Iba1 were the best differentiators between the two groups. Specifically, GFAP (d = 
15.19; p<0.0001) in the bCC and Iba1 (d = 10.23; p<0.0001) in the aCC were the best 
differentiators between the two groups. All histological measures for each segment of the 
corpus callosum are presented in Table 1. 
Diffusion MRI Assessment 
For the DT metrics (FA, MD and D┴), results consistent with previous reports 
throughout the entire CC of the CPZ mice were observed (i.e. reduced FA and increased 
MD and D┴ in comparison to NC mice, except for the FA in the aCC). D|| was significantly 
increased in the aCC and bCC, but did not change in the pCC. All DT metrics for each 
segment of the corpus callosum are presented in Table 2. 
All kurtosis metrics in the CPZ mice showed significant decreases, except for K|| 
which did not change in the aCC.  All DK metrics for each segment of the corpus callosum 
are presented in Table 3. 
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For the WMM metrics, CPZ mice had a significant AWF decrease in the entire CC, 
more intensely in the bCC and pCC. Significant Da increase was only seen in the bCC, 
with no significant change in the aCC or pCC. For the extra axonal metrics, De,||  showed a 
slight increase in the bCC and a decrease in pCC, with no change in the aCC; De,┴ 
increased in both bCC and pCC, with no change in the aCC. A significant decrease in 
tortuosity was seen in the bCC, and more intensely in the pCC, with no change in the 
aCC. All WMM metrics for each segment of the corpus callosum are presented in Table 4. 
 In the aCC, AWF (d = 2.6; p<0.0001), K┴ (d = 2.0; p=0.001) and MK (d = 1.5; 
p=0.005) showed the most sensitivity between groups with respect to yielding statistically 
significant p-values and high Cohen's d values. In the bCC, where demyelination was 
especially pronounced, D┴ (d = 4.1; p<0.0001), MD (d = 3.8; p<0.0001), AWF (d = 3.6; 
p<0.0001) and K┴, (d = 3.1; p<0.0001) yielded the best differentiation. In the pCC, D┴ (d = 
3.4; p<0.0001), FA (d = 2.4; p<0.0001) and AWF (d = 2.3; p=0.0001) best differentiated 
the two groups. 
Correlation between Diffusion and Histological Metrics 
A series of Spearman rank-order correlations were conducted in order to 
determine if any relationships existed between the diffusion metrics and the morphological 
metrics for the entire CC. This correlation analysis was performed for the entire CC for 
each group (control and cuprizone) separately (intra-group correlations). No significant 
correlations were detected in the control group, except for a negative correlation between 
FA and Iba1 (r(28) = -0.449; p=0.01) and a positive correlation between MK and Iba1 (r 
(28) = 0.393; p= 0.03). 
 There was a statistically significant relationship between diffusion and 
morphological metrics for the CPZ group. Solochrome, a myelin marker, correlated with all 
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diffusion metrics, except De,|| and α. The strongest correlation was found between 
Solochrome and MD (r(28) = 0.837; p<0.0001), followed by FA (r(28) = -0.637; p=0.0001), 
D┴ (r(28) = -0.672; p<0.0001), and De,┴ (r(28) = 0.623; p=0.0002). The inflammatory 
marker for microglia, Iba1, also correlated with several diffusion metrics, but the GFAP 
marker for astrocyte reactivity correlated only with D|| (r(28) = -0.441; p=0.01). No 
correlation was observed for the marker of neurodegeneration (amino cupric silver) with 
any diffusion metric (Table 5).    
DISCUSSION:  
This study is the first to use DK and associated WMM metrics to investigate the 
non-Gaussian diffusion patterns of chronic demyelination observed in the cuprizone 
mouse model. We demonstrated the ability of DK and WMM metrics to detect the CC 
white mater changes and inflammatory response associated with cuprizone-induced 
demyelination. Our results also replicate previous studies utilizing DTI (11-20).  
 The morphological assessment revealed demyelination with a rostro-caudal 
gradient (i.e., more intense in the body and posterior segment of the corpus callosum), 
accompanied by a mild degree of axonal damage and intense inflammatory response. 
These results are consistent with several previous studies (4-8) that reported activation of 
microglia and astrocytosis, predominantly in the caudal CC, associated with the 
breakdown of the myelin. Differently from the normal morphological aspect that shows 
less myelinated axons in the aCC compared with bCC and pCC (56), in the chronic stage 
of demyelination the rostral segment of the CC is less affected in the process (14,16) and 
maintain more myelinated axons compared with both bCC and pCC (Table 1). 
 DT, DK and WMM metrics estimated well the extent of the demyelination process 
in the bCC and pCC, but DT metrics underestimated the disease process at the aCC 
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level. In the aCC, FA was not able to distinguish the two groups, and the diffusivity metrics 
showed marginal statistical significance, probably due to the greatest morphological 
heterogeneity being present at this level. Indeed, it is well-described (14,16) that the 
anterior part of the CC is less damaged during the cuprizone toxicity-induced 
demyelination process, presenting with a heterogeneous pattern of demyelination, as our 
morphological results also demonstrated (Figure 3). Similar to DT metrics, changes in the 
DK and WMM metrics were more evident in the bCC and pCC, with statistical significance 
differentiating the two animal groups. However, DK and WMM metrics were also able to 
capture the heterogeneity of the process in the aCC, and despite the variability in the 
degree of myelin loss at this level, we observed significant decrease in MK, K┴ and AWF, 
likely reflecting myelin breakdown and decrease in axonal packing which, albeit less, is 
still morphologically evident at this level.  
Based on the morphological changes represented by myelin breakdown and loss, 
one would expect fewer diffusion barriers and less structural complexity in the CC 
microenvironment, thereby causing a decrease in the diffusion metrics. Indeed, 
associated with an increase in the diffusivities (MD, D|| and D┴) we observed decreases in 
MK, K||, K┴ and AWF.  
However, since the aCC, bCC and pCC differ in the degree of myelination, axonal 
density, distribution and alignment, which lead to differences in extra cellular space, not all 
the dMRI changes are straightforward to interpret. Additionally, the morphological 
changes due to the toxic process is complex, not only with demyelination and presence of 
myelin debris, but with damaged axons, decrease in axonal diameter and changes in 
cellularity (apoptotic oligodendrocytes, reactive microglia and astrocytes) (5-8).  
Therefore, the individual components of this process and the combination of 
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morphological components have different effects on the behavior of water diffusion as 
reflected in the dMRI metrics. This is evident in the WMM metrics for example, where Da 
increased in bCC, but did not significantly change in the aCC and pCC. We can speculate 
that because bCC has a broader distribution containing axons with large and mid-size 
(mixed) caliber, the decrease in axonal diameter that occurs during the toxic process in 
this chronic stage (62) narrows the axonal distribution, leading to a better alignment of the 
axons, and subsequently increase in Da.  Additionally, reactive astrocytes known for high 
diffusion rates, and intimately associated with small damaged axons, may also contribute 
to the increase in Da. In this segment, the demyelination process leads to an increase in 
De,┴ and De,||, but a decrease in tortuosity due to the stronger effect of the De,┴ increase 
(Table 4). 
On the other hand, in the pCC, which has a high density of small packed axons, 
the dMRI patterns behaved slightly differently. As a result of the demyelination process 
De,┴ increased; however, at this level, the uneven demyelination probably creates 
imperfections in the original dense fiber alignment resulting in less tension of the fibers 
and changing the geometry of the extracellular space, which may be the reason we see 
decrease in De,||. In this segment, the effect size of the De,┴ increase is higher than the 
decrease in De,||, explaining the decrease in tortuosity. 
One interesting observation that may appear to be contradictory to previous results 
(12-14,19,63) is the increase in D|| in the aCC and bCC. However, previous studies 
showed a decrease in D|| in the acute phase of the demyelinating process, not in the 
chronic phase. Indeed, both in vivo and ex vivo previous studies reported no significant 
difference or slightly increased D|| after 6 weeks of toxin exposure (11,12,16,20). Another 
possible explanation for this difference is that DKI-derived estimates of diffusivities are 
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assumed to provide more accurate estimates of diffusion metrics (49), and kurtosis 
metrics are less sensitive to CSF partial volume (64). 
The strong correlation between dMRI metrics and Solocrome, particularly MD, FA, D┴ and 
De,┴ confirms that these metrics are sensitive to myelin abnormalities. The inflammatory 
marker for microglia, Iba1, also correlated with several diffusion metrics, particularly with 
D┴, which is in agreement with the fact that microglia infiltration is correlated with intense 
myelin breakdown (4-8). The lack of correlation between the amino cupric silver and the 
diffusion metrics is an unexpected observation and needs to be investigated in a future 
study. Similarly, the presence of a correlation between Iba1 with FA (negative) and MK 
(positive) in the CC of normal mice is also interesting, but at this time the reason is still 
unknown and needs to be further investigated. Likewise, the presence of a correlation 
between Iba1 with FA (negative) and MK (positive) in the CC of normal mice is interesting, 
but at this time the reason is still unknown and needs to be further investigated. 
Confirming the WMM assumptions for regions such as the CC, which is formed 
predominantly with WM fiber bundles aligned in a consistent parallel orientation (57,65), 
the DKI-WMM metrics provided unique information regarding the underlying 
morphological alterations associated with the demyelination process, particularly in the 
rostral segment of the CC, where DKI-WMM metrics such MK, K┴ and AWF were more 
sensitive to the heterogeneity of the toxic process. 
One limitation of this study is the fact that we did not investigate the temporal 
process of demyelination and/or the recovery phase. We acknowledge the importance of 
investigating water diffusion at those stages of the pathological process, but since we 
were investigating new diffusion metrics we decided to focus only on the phase where the 
demyelination is intense and complete. Therefore, these results should be carefully 
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interpreted since they represent only the chronic phase and would probably be different in 
the acute and/or recovery stage. Additionally, technical limitations for both dMRI and 
histology techniques, with different spatial resolutions, should be considered when 
interpreting the results. Finally, partial volume effects due to the larger voxel size, 
particularly in the body of the CC, may have had an effect in the results; however it is 
known that DKI metrics are less sensitive to partial volume effects (64), and masking for 
CSF using MD > 1.5um2/ms, reduced the possibility of the results being determined by 
CSF contamination.  
In conclusion, we have demonstrated that kurtosis and WMM metrics can be used 
as markers of the morphological changes associated with chronic demyelination in the 
cuprizone model. We have found that DK and WMM metrics provide complementary 
information enhancing the sensitivity to the morphological heterogeneity of the disease 
processes seen in the rostral segment of the corpus callosum. However, further studies 
are needed to delineate the underlying mechanisms associated with the temporal 
changes in the dMRI parameters, particularly with the WMM metrics. In part, these results 
also help validate these new WMM metrics, which should assist in the interpretation of 
results from future DKI studies using these metrics to investigate WM abnormalities in 
neurological diseases. 
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Table 1: Histological estimates (mean ± standard error, p-values, percentage differences 
and Cohen’s d) for each segment of the corpus callosum.  
 
 
    Solochrome Amino GFAP Iba1   
    Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM   
  NC 171.37 ± 0.73 211.50 ± 0.57 169.79 ± 1.15 216.44 ± 0.34   
aCC CPZ 177.15 ± 1.42 204.66 ± 1.75 86.53 ± 2.49 196.03 ± 0.88   
  p-values p<0.002 p<0.002 p<0.0001 p<0.0001   
  Cohen's d 1.70 1.75 14.32 10.23   
  % Difference 3.37  -3.23 -49.03 -9.43   
              
bCC NC 168.82 ± 0.54 201.22 ± 0.62 168.64 ± 1.19 217.08 ± 0.53   
  CPZ 183.50 ± 0.68 193.38 ± 2.16 84.36 ± 2.33 196.38 ± 0.97   
  p-values p<0.0001 p<0.003 p<0.0001 p<0.0001   
  Cohen's d 7.99 1.65 15.19 8.84   
  % Difference 8.69 -3.89  -49.98 -9.54   
              
pCC NC 168.92 ± 0.76 200.76 ± 1.08 167.23 ± 1.24 222.06 ± 1.21   
  CPZ 179.89 ± 1.21 191.62 ± 1.29 93.95 ± 2.79 203.95 ± 1.74   
  p-values p<0.0001 p<0.0001 p<0.0001 p<0.0001   
  Cohen's d 3.62 2.56 11.31 4.03   
  % Difference 6.49 -4.55  -43.82 -8.15   
              
Histological quantification (grey mean intensity) showing significant decrease in myelin 
stain (Solochrome) and increase in neurorodegeneration (Amino) and inflammatory 
markers ((GFAP) and IBa1) in the cuprizone group. Note that higher mean intensity (MI) 
values correspond to less staining. Percentage difference calculated as (MI cuprizone – 
MI control)  x 100)/MI control. Corpus callosum rostral (aCC), middle (bCC) and caudal 
(pCC) levels; control group (NC) and cuprizone group (CPZ); p values for group 
differences.  
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Table 2: DT metrics estimates (mean ± standard error, p-values, percentage differences 
and Cohen’s d) for each segment of the corpus callosum.  
 
    FA MD D// D┴   
    Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM   
      μm2/ms μm2/ms μm2/ms   
  NC 0.26 ± 0.01 1.00 ± 0.02 1.24 ± 0.02 0.87 ± 0.02   
aCC CPZ 0.24 ± 0.01 1.06 ± 0.02 1.30 ± 0.02 0.94 ± 0.02   
  p-values n/s p=0.02 p=0.04 p=0.03   
  Cohen's d 0.80 1.18 1.03 1.14   
  % Difference -8.53 6.53 4.51 7.80   
              
bCC NC 0.32 ± 0.00 0.94 ± 0.01 1.20 ± 0.01 0.80 ± 0.01   
  CPZ 0.27 ± 0.01 1.07 ± 0.01 1.32 ± 0.02 0.94 ± 0.01   
  p-values p<0.0001 p<0.0001 p<0.0001 p<0.0001   
  Cohen's d 2.84 3.79 2.48 4.12   
  % Difference -16.88 13.66 9.98 16.56   
              
pCC NC 0.46 ± 0.01 0.95 ± 0.01 1.51 ± 0.03 0.68 ± 0.01   
  CPZ 0.36 ± 0.01 1.00 ± 0.01 1.43 ± 0.03 0.78 ± 0.01   
  p-values p<0.0001 p=0.01 n/s p<0.0001   
  Cohen's d 2.45 1.36 0.83 3.41   
  % Difference -21.65 4.51 -4.85 15.49   
 
DT metrics showing changes between the control group (NC) and cuprizone group (CPZ); 
fractional anisotropy (FA); mean diffusivity (MD); axial diffusivity (D//); radial diffusivity (D┴); 
p values are for group differences.  
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Table 3: DK metrics estimates (mean ± standard error, p-values, percentage differences 
and Cohen’s d) for each segment of the corpus callosum.  
 
            
    MK K// K┴  
    Mean ± SEM Mean ± SEM Mean ± SEM   
  NC 0.69 ± 0.02 0.77 ± 0.02 0.78 ± 0.02   
aCC CPZ 0.62 ± 0.01 0.75 ± 0.02 0.67 ± 0.02   
  p-values p=0.005 n/s p=0.001   
  Cohen's d 1.46 0.33 1.97   
  % Difference -9.62 -2.59 -13.85   
            
bCC NC 0.64 ± 0.02 0.72 ± 0.02 0.68 ± 0.04   
  CPZ 0.49 ± 0.02 0.58 ± 0.02 0.49 ± 0.02   
  p-values p=0.0001 p=0.0001 p<0.0001   
  Cohen's d 2.79 2.27 3.12   
  % Difference -23.56 -20.19 -28.42   
            
pCC NC 0.65 ± 0.01 0.70 ± 0.01 0.68 ± 0.04   
  CPZ 0.54 ± 0.02 0.63 ± 0.01 0.48 ± 0.05   
  p-values p=0.001 p=0.001 p=0.005   
  Cohen's d 1.93 1.92 1.52   
  % Difference -16.80 -10.14 -28.40   
            
DK metrics showing changes between the control group (NC) and cuprizone group (CPZ); 
mean kurtosis (MK); axial kurtosis (K//); radial kurtosis (K┴); p values are for group 
differences.  
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Table 4: WMM metrics estimates (mean ± standard error, p-values, percentage 
differences and Cohen’s d) for each segment of the corpus callosum.  
 
WMM metrics showing changes between the control group (NC) and cuprizone group (CPZ); 
axonal water fraction (AWF); the intrinsic diffusivity inside the axons, (Da); the axial and radial 
diffusivities in the extra-axonal space, (De,||) and (De,┴) respectively; and the tortuosity (α); p 
values are for group differences. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    AWF Da De,|| De,┴ α  
    Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM   
      μm2/ms μm2/ms μm2/ms     
  NC 0.26 ± 0.0 0.57 ± 0.02 1.59 ± 0.03 1.11 ± 0.03 1.43 ± 0.02   
aCC CPZ 0.24 ± 0.0 0.58 ± 0.01 1.64 ± 0.02 1.17 ± 0.02 1.40 ± 0.02   
  p-values p<0.0001 n/s n/s n/s n/s   
  Cohen's d 2.57 0.17 0.58 0.75 0.56   
  % Difference -8.56 1.76 2.83 5.21 -2.27   
                
bCC NC 0.25 ± 0.0 0.56 ± 0.02 1.53 ± 0.02 1.01 ± 0.02 1.51 ± 0.02   
  CPZ 0.21 ± 0.0 0.67 ± 0.02 1.61 ± 0.03 1.12 ± 0.01 1.44 ± 0.01   
  p-values p<0.0001 p=0.001 p=0.04 p=0.0001 p=0.01   
  Cohen's d 3.61 1.79 1.01 2.34 1.30   
  % Difference -16.87 19.18 5.22 10.76 -5.16   
                
pCC NC 0.26 ± 0.0 0.60 ± 0.02 1.92 ± 0.04 0.86 ± 0.02 2.24 ± 0.07   
  CPZ 0.21 ± 0.01 0.55 ± 0.02 1.78 ± 0.04 0.94 ± 0.01 1.88 ± 0.05   
  p-values p=0.0001 n/s p=0.03 p=0.001 p=0.001   
  Cohen's d 2.26 0.87 1.12 1.85 1.90   
  % Difference -17.83 -8.82 -7.60 9.77 -16.06   
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Table 5: Spearman’s correlation between diffusion metrics and histological quantitative 
measures for the cuprizone group (CPZ); Correlation Coefficient significant (bold) at: * 
p≤0.05, ** p≤0.01, and *** p≤0.001 (2-tailed). 
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FA MD D|| D┴ MK K|| K┴ AWF Da De|| De┴ α
Solochrome - 0.637*** 0.837***  0.518** 0.672*** - 0.510** - 0.495** - 0.498** - 0.365*  0.431* 0.271  0.623*** -0.276
Amino 0.035 -0.080 -0.085 0.033 -0.003 -0.258 0.279 -0.239 -0.347 -0.072 0.043 -0.157
GFAP 0.042 -0.161 -0.441** 0.184 0.019 -0.111 0.225 0.175 -0.207 -0.321 0.072 0.018
Iba1 -0.340 0.175 - 0.376* 0.649*** - 0.423* -0.483** -0.024 -0.326 -0.316 - 0.435*  0.434* - 0.365*
 
 
 
 
LEGENDS 
Figure 1: 
First Row: Coronal diagram of the mouse brain with slices (Paxinos’ mouse Brain Atlas) 
centered at anatomical positions corresponding to the bregma location for corpus 
callosum (CC) rostral (aCC), middle (bCC) and caudal (pCC) levels; Second Row: 
Representative fraction anisotropy (FA) maps  (NC mice) with CC ROIs at each level. 
Third Row: Representative of the Solochrome stain (NC mice) with CC ROIs at each 
level. 
 
 
Figure 2: 
Histological examples (4x) of the solochrome (A) and amino cupric silver (B) stains, and 
GFAP (C) and Iba1 (D) immunohistochemistry with detailed insert (100x) at the body from 
of the CC. Control group (NC) and cuprizone group (CPZ). Scale bar = 100 µm. 
 
 
Figure 3: 
Morphological heterogeneity of the demyelination process in the cuprizone group; the 
figure illustrates histological sections from 3 cuprizone mice, showing the different degree 
of demyelination in the aCC (177.15±4.50) and similar, complete demyelination at the 
bCC (183.50±2.14) and pCC(179.89±3.83)  for all three mice. Note the higher SD at the 
level of the aCC when compared is bCC and pCC, reflecting the morphological 
demyelination heterogeneity in the aCC. Intensity values as mean ± SD (arbitrary units). 
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